The weekly litigation news digest is live. Subscribe now

Troponin As Marker For Intermittent Atrial Fibrillation

Patent No. EP3088900 (titled "Troponin As Marker For Intermittent Atrial Fibrillation") was filed by F Hoffmann LA Roche on Oct 17, 2012. The application was issued on Aug 12, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREMay 12, 2021GRIFFIN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3088900

F HOFFMANN LA ROCHE
Application Number
EP16175468A
Filing Date
Oct 17, 2012
Status
Revoked
Feb 23, 2024
Publication Date
Aug 12, 2020